Project leads
Collaborators

AMH, Inhibin A, FSH, and Ovarian Cancer Risk in the JANUS Serum Bank

Nicolas Wentzensen

2 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Follow

Louise Brinton

National Cancer Institute (NIH)

Rockville, United States

Elisabete Weiderpass

Cancer Registry of Norway

Oslo, Norway

Nicolas Wentzensen

National Cancer Institute (NIH)

Rockville, United States

Related projects

Nathaniel Rothman

Studies in the Janus Cohort

Nathaniel Rothman

DDT, PCBs, and Other Persistent Organohalide Chemicals in the JANUS Cohort

Hematology and hematologic malignancies Pathology

Thomas A Sellers

Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)

Heather Elizabeth Wheeler

Pharmacogenomics of the Chemotherapeutic Agent Paclitaxel

Trachea, bronchus and lung Ovary Breast

Eleftherios P Diamandis

An Integrated Systems Biology Approach for Ovarian Cancer Biomarker Discovery

Theodore Brown

Impact of VEPH1 on cancer associated signaling pathways in the promotion of ovarian cancer

Eric Asselin

Gene therapy of chemoresistant and metastatic cancers (CANADA RESEARCH CHAIRHOLDER)

Ovary Corpus uteri

Bernard E Weissman

The Tumor Suppressor Role of SMARCA4 in SCCOHT